Drug:
Reaction: PARAESTHESIA
20250101 - 20251231
No. 2601 - 2700
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 2601 | 25314309 |
US |
72 | 1 |
Hepatic cirrhosis, Hot flush, Paraesthesia, |
||||
DAROLUTAMIDE, DAROLUTAMIDE, |
||||
| 2602 | 25314328 |
US |
41 | 1 |
Headache, Paraesthesia, Pruritus, Nightmare, Nausea, Off label use, |
||||
AVAPRITINIB, AVAPRITINIB, LOSARTAN POTASSIUM, FLUTICASONE PROPIONATE, TRIPROLIDINE HCL, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, SUMATRIPTAN, OMEPRAZOLE MAGNESIUM, PROPRANOLOL HYDROCHLORIDE, MONTELUKAST SODIUM, LEVOCETIRIZINE DIHYDROCHLORIDE, |
||||
| 2603 | 25314344 |
CA |
36 | 1 |
Myelitis, Guillain-Barre syndrome, Swelling of eyelid, Visual acuity reduced, Photosensitivity reaction, Hypersensitivity, Keratitis, Injection site discomfort, Hypoaesthesia, Sensory loss, Musculoskeletal stiffness, Asthenia, Dyskinesia, Loss of proprioception, Cough, Sputum increased, Increased upper airway secretion, Influenza, Paraesthesia, Infection, Pain, Granuloma, Drug effective for unapproved indication, Off label use, Device difficult to use, Wrong technique in device usage process, Product communication issue, Multiple use of single-use product, |
||||
ADALIMUMAB-AFZB, ADALIMUMAB-AFZB, ADALIMUMAB-AFZB, ADALIMUMAB-AFZB, |
||||
| 2604 | 25314478 |
GB |
78 | 2 |
Peripheral coldness, Urinary hesitation, Paraesthesia, Pain in extremity, Pyrexia, Chest pain, |
||||
ZOLEDRONIC ACID, LOSARTAN POTASSIUM, IVERMECTIN, LANSOPRAZOLE, LEVOTHYROXINE, |
||||
| 2605 | 25314614 |
AU |
39 | 2 |
Hypoaesthesia, Paraesthesia, |
||||
SEMAGLUTIDE, |
||||
| 2606 | 25314745 |
CA |
70 | 2 |
Anxiety, Blood pressure increased, Pain, Rubber sensitivity, Stress, Breast pain, Medication overuse headache, Communication disorder, Paraesthesia, Headache, Off label use, Drug ineffective for unapproved indication, Contraindicated product administered, Drug ineffective, |
||||
ERENUMAB-AOOE, PROPRANOLOL HYDROCHLORIDE, OXYCODONE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE AND ACETAMINOPHEN TABLETS, MAGNESIUM, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, METOPROLOL TARTRATE, METOPROLOL, CALCIUM, ERGOCALCIFEROL, GABAPENTIN, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, ATORVASTATIN CALCIUM, NIFEDIPINE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, FLUOXETINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, RABEPRAZOLE, MIRTAZAPINE, SERTRALINE HYDROCHLORIDE, VALPROATE SODIUM, TOPIRAMATE, TOPIRAMATE, TOPIRAMATE SPINKLE, |
||||
| 2607 | 25314900 |
US |
69 | 2 |
Mental disorder, General physical health deterioration, Paraesthesia, Finger deformity, Arthralgia, Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 2608 | 25315192 |
US |
55 | 2 |
Injection site haemorrhage, Product administration error, Injection site pain, Nodule, Paraesthesia, Hypoaesthesia, Neurodermatitis, Product dose omission in error, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 2609 | 25303660 |
US |
50 | 2 |
Injection site reaction, Headache, Paraesthesia, Blood pressure increased, Nausea, Fatigue, Decreased appetite, Psoriasis, Off label use, |
||||
CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, SELENIUM, FISH OIL, LISINOPRIL, FLUTICASONE PROPIONATE, OXYBUTYNIN CHLORIDE, CLONAZEPAM, ESCITALOPRAM, PREDNISONE, |
||||
| 2610 | 25303721 |
BE |
||
Feeling hot, Headache, Erythema, Erythema, Erythema, Rash, Rash pruritic, Nausea, Paraesthesia, Tachycardia, Hypotension, |
||||
INFLIXIMAB, |
||||
| 2611 | 25303821 |
US |
50 | 2 |
Monoplegia, Paraesthesia, Hypoaesthesia, |
||||
OZANIMOD HYDROCHLORIDE, |
||||
| 2612 | 25303836 |
US |
||
Blood calcium decreased, Paraesthesia, |
||||
ROMOSOZUMAB-AQQG, |
||||
| 2613 | 25304043 |
EU |
42 | 2 |
Off label use, Paraesthesia, Drug ineffective, |
||||
PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, BORTEZOMIB FOR INJECTION, BORTEZOMIB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, AZATHIOPRINE, |
||||
| 2614 | 25304245 |
US |
38 | 2 |
Loss of consciousness, Injection site swelling, Injection site bruising, Paraesthesia oral, Dizziness, Anxiety, Tooth injury, Paraesthesia, Injection site erythema, |
||||
ASFOTASE ALFA, |
||||
| 2615 | 25304310 |
CA |
2 | |
Fatigue, Muscular weakness, Blindness, Hypoaesthesia, Neuralgia, Paraesthesia, Balance disorder, Pneumonia, |
||||
RITUXIMAB, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, |
||||
| 2616 | 25304821 |
IN |
55 | 1 |
Neurotoxicity, Demyelination, Toxicity to various agents, Gait disturbance, Paraesthesia, Intention tremor, Romberg test positive, Hyperreflexia, Nausea, Vomiting, Dysarthria, Ataxia, Hypoaesthesia, |
||||
METRONIDAZOLE, METRONIDAZOLE TOPICAL, METRONIDAZOLE, METRONIDAZOLE TOPICAL, METRONIDAZOLE, METRONIDAZOLE TOPICAL, METRONIDAZOLE, METRONIDAZOLE TOPICAL, CEFTRIAXONE, CEFTRIAXONE SODIUM, |
||||
| 2617 | 25304828 |
US |
44 | 1 |
Paraesthesia, Eyelid ptosis, Migraine, Vision blurred, |
||||
ESKETAMINE HYDROCHLORIDE, ONABOTULINUMTOXINA, |
||||
| 2618 | 25305124 |
US |
58 | 2 |
Seizure, Hypoaesthesia, Paraesthesia, |
||||
EVOLOCUMAB, |
||||
| 2619 | 25305447 |
FR |
43 | 2 |
Interstitial lung disease, Asthenia, Abdominal pain, Weight increased, Paraesthesia, Aphasia, |
||||
BRIGATINIB, LORLATINIB, |
||||
| 2620 | 25305856 |
US |
2 | |
Off label use, Paraesthesia, Flushing, Rash, Swollen tongue, Throat irritation, Panic attack, |
||||
ESKETAMINE HYDROCHLORIDE, ESKETAMINE HYDROCHLORIDE, ESKETAMINE HYDROCHLORIDE, CLONIDINE, EPTINEZUMAB-JJMR, LORATADINE, LORATADINE ORAL, |
||||
| 2621 | 25306087 |
65 | 1 | |
Dizziness, Paraesthesia, Paraesthesia, Hypoglycaemia, Drug interaction, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, FISH OIL, |
||||
| 2622 | 25306600 |
US |
56 | 2 |
Medical procedure, Paraesthesia, |
||||
ONABOTULINUMTOXINA, VOCLOSPORIN, |
||||
| 2623 | 25306983 |
GB |
69 | 1 |
Muscle spasms, Paraesthesia, Hemiparesis, |
||||
BISOPROLOL FUMARATE, LOSARTAN, CLOPIDOGREL, CLOPIDOGREL BISULFATE, LANSOPRAZOLE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 2624 | 25307257 |
US |
62 | 2 |
Neutropenia, Off label use, Product use issue, Fatigue, Alopecia, Anaemia, Nausea, Nerve injury, Burning sensation, Hypoaesthesia, Paraesthesia, Pain, |
||||
PALBOCICLIB, |
||||
| 2625 | 25307595 |
US |
||
Spinal cord disorder, Feeling abnormal, Paraesthesia, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, EPINEPHRINE, ADRENALINUM, MOMETASONE FUROATE AND FORMOTEROL FUMARATE DIHYDRATE, DIPHENHYDRAMINE HYDROCHLORIDE, ALBUTEROL SULFATE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, METHYLPREDNISOLONE SODIUM SUCCINATE, |
||||
| 2626 | 25307646 |
FR |
43 | 2 |
Interstitial lung disease, Asthenia, Abdominal pain, Weight increased, Paraesthesia, Aphasia, |
||||
LORLATINIB, BRIGATINIB, |
||||
| 2627 | 25307943 |
US |
45 | 1 |
Paraesthesia, |
||||
INSULIN LISPRO, |
||||
| 2628 | 25308060 |
US |
74 | 2 |
Asthenia, Tremor, Muscular weakness, Fatigue, Paraesthesia, Full blood count decreased, |
||||
LENALIDOMIDE, |
||||
| 2629 | 25308223 |
US |
75 | 1 |
Lip swelling, Paraesthesia, Paraesthesia oral, |
||||
EVOLOCUMAB, |
||||
| 2630 | 25308416 |
US |
57 | 2 |
Injection site haemorrhage, Injection site urticaria, Injection site discomfort, Paraesthesia, Eyelid skin dryness, Swelling of eyelid, Skin exfoliation, Condition aggravated, Injection site rash, Injection site pain, Injection site erythema, Product storage error, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 2631 | 25308466 |
US |
79 | 2 |
Sciatica, Paraesthesia, Pruritus, Eczema, |
||||
DUPILUMAB, |
||||
| 2632 | 25308757 |
US |
52 | 1 |
Paraesthesia, Fatigue, Stress at work, Regurgitation, Condition aggravated, Pruritus, Insomnia, Pain in extremity, Illness, Pain, Rash macular, |
||||
DUPILUMAB, |
||||
| 2633 | 25308849 |
US |
67 | 2 |
Neck pain, Eosinophil count decreased, Lacrimation increased, Vision blurred, Paraesthesia, Sinusitis, Sinus congestion, Cough, Drainage, Peripheral swelling, Joint stiffness, Oxygen saturation decreased, Blood glucose increased, Chronic obstructive pulmonary disease, Dyspnoea, Incorrect dose administered, |
||||
DUPILUMAB, DUPILUMAB, ALBUTEROL SULFATE, ALBUTEROL, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 2634 | 25297847 |
US |
36 | 2 |
Upper respiratory tract infection, Paraesthesia, Feeling abnormal, Product dose omission issue, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 2635 | 25298218 |
US |
2 | |
Injection site rash, Pain, Neuralgia, Dry mouth, Paraesthesia, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 2636 | 25299056 |
GB |
30 | 1 |
Paraesthesia, Palpitations, |
||||
CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, |
||||
| 2637 | 25299302 |
EU |
48 | 1 |
Immune-mediated hyperthyroidism, Paraesthesia, |
||||
TRASTUZUMAB, TRASTUZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, OXALIPLATIN, OXALIPLATIN, |
||||
| 2638 | 25299342 |
US |
64 | 2 |
Feeling hot, Paraesthesia, |
||||
QUETIAPINE FUMARATE, QUETIAPINE, VEDOLIZUMAB, ATORVASTATIN CALCIUM, FENOFIBRATE, |
||||
| 2639 | 25299346 |
US |
73 | 1 |
Therapeutic response unexpected, Paraesthesia, Sensory disturbance, |
||||
CAPSAICIN, |
||||
| 2640 | 25299349 |
US |
2 | |
Application site pain, Pain, Paraesthesia, |
||||
CAPSAICIN, GABAPENTIN, |
||||
| 2641 | 25299424 |
US |
53 | 2 |
Neuropathy peripheral, Paraesthesia, Bursitis, Neuralgia, |
||||
FREMANEZUMAB-VFRM, |
||||
| 2642 | 25299491 |
EU |
85 | 2 |
Paraesthesia, Haemorrhagic stroke, Death, |
||||
ACALABRUTINIB, |
||||
| 2643 | 25299501 |
US |
1 | |
Neuropathy peripheral, Limb discomfort, Paraesthesia, Fatigue, Diarrhoea, Dizziness, Decreased appetite, |
||||
TRAMETINIB, TRAMETINIB, DABRAFENIB, DABRAFENIB, |
||||
| 2644 | 25300294 |
GB |
24 | 2 |
Paraesthesia, Headache, Rash erythematous, Dizziness, Muscular weakness, Nausea, |
||||
MIRTAZAPINE, |
||||
| 2645 | 25300534 |
TH |
64 | 2 |
Urticaria, Face oedema, Paraesthesia, Heart rate increased, Hypotension, |
||||
IOVERSOL, |
||||
| 2646 | 25300538 |
US |
76 | 1 |
Peripheral nerve injury, Muscular weakness, Paraesthesia, |
||||
ATENOLOL, AMLODIPINE, |
||||
| 2647 | 25300887 |
US |
2 | |
Respiratory disorder, Sinus disorder, Anal incontinence, Tremor, Speech disorder, Eye movement disorder, Back pain, Urinary incontinence, Aphasia, Disturbance in attention, Decreased appetite, Poor quality sleep, Dysstasia, Visual impairment, Memory impairment, Pain in extremity, Hypoaesthesia, Paraesthesia, Arthralgia, |
||||
INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, FUROSEMIDE, GABAPENTIN, LEVOTHYROXINE, MIRTAZAPINE, SEMAGLUTIDE, PROMETHAZINE, |
||||
| 2648 | 25301124 |
US |
61 | 2 |
Depression, Anxiety, Fatigue, Nausea, Nerve injury, Hypoaesthesia, Paraesthesia, Pain in extremity, Burning sensation, |
||||
PALBOCICLIB, FULVESTRANT, PANTOPRAZOLE, GABAPENTIN, DULOXETINE HYDROCHLORIDE, DULOXETINE, ERGOCALCIFEROL, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, MELATONIN, |
||||
| 2649 | 25301375 |
US |
2 | |
Migraine, Paraesthesia, Off label use, |
||||
CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, |
||||
| 2650 | 25301641 |
US |
2 | |
Blister, Paraesthesia, Maternal exposure during breast feeding, Nasopharyngitis, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 2651 | 25301769 |
US |
60 | 2 |
Paraesthesia, Dyspnoea, Headache, Fatigue, Diarrhoea, |
||||
ABEMACICLIB, ABEMACICLIB, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, FUROSEMIDE, ERGOCALCIFEROL, |
||||
| 2652 | 25302139 |
IT |
||
Headache, Paraesthesia, Product substitution issue, Pain in extremity, Asthenia, |
||||
RIVAROXABAN, RAMIPRIL, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, |
||||
| 2653 | 25302865 |
CA |
44 | 2 |
Contraindicated product administered, Muscle injury, Intentional product use issue, Musculoskeletal pain, Muscle spasms, Medication error, Lung disorder, Drug intolerance, Drug ineffective, Maternal exposure during pregnancy, Musculoskeletal stiffness, Nasopharyngitis, Night sweats, Obesity, Oedema, Oedema peripheral, Off label use, Osteoarthritis, Pain, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Swelling, Maternal exposure during pregnancy, Porphyria acute, Prescribed overdose, Product use in unapproved indication, Product use issue, Pruritus, Psoriatic arthropathy, Pyrexia, Rash, Rectal haemorrhage, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Sinusitis, Sleep disorder, Synovitis, Therapeutic product effect decreased, Therapy non-responder, Treatment failure, Type 2 diabetes mellitus, Urticaria, Weight decreased, Weight increased, Wheezing, Wound, Wound infection, X-ray abnormal, Pain in extremity, Paraesthesia, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Systemic lupus erythematosus, |
||||
FOSAPREPITANT DIMEGLUMINE, |
||||
| 2654 | 25302895 |
US |
12 | 1 |
Spinal cord disorder, Paraesthesia, Feeling abnormal, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, EPINEPHRINE, ADRENALINUM, MOMETASONE FUROATE AND FORMOTEROL FUMARATE DIHYDRATE, DIPHENHYDRAMINE HYDROCHLORIDE, ALBUTEROL SULFATE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, METHYLPREDNISOLONE SODIUM SUCCINATE, |
||||
| 2655 | 25303159 |
US |
2 | |
Pain, Injection site pain, Gastrointestinal disorder, Paraesthesia, Hypoaesthesia, Headache, Drug ineffective, |
||||
CERTOLIZUMAB PEGOL, DESVENLAFAXINE SUCCINATE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, CARIPRAZINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, |
||||
| 2656 | 25303334 |
US |
2 | |
Weight decreased, Paraesthesia, Burning sensation, |
||||
CERTOLIZUMAB PEGOL, AZATHIOPRINE, |
||||
| 2657 | 25294388 |
US |
73 | 1 |
Paraesthesia, Incorrect dose administered, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 2658 | 25294803 |
US |
34 | 2 |
Pruritus, Paraesthesia, Product dose omission issue, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 2659 | 25294813 |
US |
58 | 2 |
Hypoaesthesia, Paraesthesia, Musculoskeletal discomfort, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 2660 | 25295251 |
US |
53 | 1 |
Paraesthesia, Malaise, Dermatitis atopic, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 2661 | 25295887 |
US |
2 | |
Eczema, Rash pustular, Maternal exposure during breast feeding, Dry mouth, Dry eye, Polydipsia, Headache, Hypoaesthesia, Paraesthesia, Anxiety, Depression, Insomnia, Urticaria, Photosensitivity reaction, Pruritus, Back pain, Arthralgia, Joint swelling, Back pain, Musculoskeletal stiffness, Muscle spasms, Muscular weakness, Myalgia, Neck pain, Keratitis, |
||||
CERTOLIZUMAB PEGOL, HYDROXYCHLOROQUINE SULFATE, ERGOCALCIFEROL, FAMOTIDINE, FLUOCINONIDE, FLUOCINONIDE TOPICAL SOLUTION USP, 0.05%, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, NAPROXEN, NAPROXEN SODIUM, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, OXYCODONE HYDROCHLORIDE, OXYCODONE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, |
||||
| 2662 | 25296855 |
US |
1 | |
Paraesthesia, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 2663 | 25297025 |
US |
2 | |
Paraesthesia, Hypoaesthesia, Dizziness, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 2664 | 25297134 |
US |
2 | |
Feeling of body temperature change, Sleep disorder, Paraesthesia, Hunger, Therapeutic response shortened, Product use issue, |
||||
CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, |
||||
| 2665 | 25297148 |
US |
35 | 2 |
Axial spondyloarthritis, Hypoaesthesia, Paraesthesia, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 2666 | 25297558 |
CH |
53 | 1 |
Chest discomfort, Hypersensitivity, Hyperhidrosis, Tachypnoea, Hyperventilation, Paraesthesia, Throat irritation, Dyspnoea, Feeling hot, Panic attack, Stress, Fatigue, Throat tightness, Tryptase increased, Skin discolouration, Restlessness, Discomfort, |
||||
RISANKIZUMAB-RZAA, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, PREDNISONE, INFLIXIMAB, |
||||
| 2667 | 25301794 |
69 | 1 | |
Flushing, Rash pruritic, Paraesthesia, Haematochezia, |
||||
EMPAGLIFLOZIN, EMPAGLIFLOZIN, |
||||
| 2668 | 25290287 |
US |
2 | |
Diarrhoea, Nausea, Decreased appetite, Muscular weakness, Gout, Paraesthesia, Nerve injury, Acne, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, NINTEDANIB, CALCIUM, MOMETASONE FUROATE, OXYGEN, 0XYGEN, FUROSEMIDE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, ONDANSETRON HYDROCHLORIDE, IPRATROPIUM BROMIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 2669 | 25291355 |
US |
43 | 2 |
Hypoaesthesia, Paraesthesia, Product dose omission in error, |
||||
DUPILUMAB, |
||||
| 2670 | 25291925 |
US |
70 | 1 |
Blood pressure increased, Heart rate decreased, Chest pain, Headache, Paraesthesia, Disorientation, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 2671 | 25292437 |
US |
8 | 2 |
Formication, Proteinuria, Temperature intolerance, Exercise tolerance decreased, Diarrhoea, Burning sensation, Paraesthesia, Abdominal pain upper, |
||||
AGALSIDASE BETA, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, LIDOCAINE AND PRILOCAINE, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, HYDROXYZINE HYDROCHLORIDE ORAL, |
||||
| 2672 | 25292707 |
US |
65 | 2 |
Pneumonia, Dyspnoea, Heart rate increased, Chest discomfort, Palpitations, Chest pain, Influenza, Tinnitus, Peripheral coldness, Tremor, Paraesthesia, Headache, Chills, Pain, Pyrexia, Arthralgia, Gait disturbance, |
||||
DUPILUMAB, |
||||
| 2673 | 25292726 |
US |
60 | 2 |
Injection site pruritus, Condition aggravated, Product dose omission issue, Hypoaesthesia, Paraesthesia, Pain, |
||||
DUPILUMAB, |
||||
| 2674 | 25292859 |
US |
38 | 2 |
Paraesthesia, Asthenia, Arthralgia, Incorrect dose administered, |
||||
DUPILUMAB, |
||||
| 2675 | 25292979 |
US |
65 | 1 |
Paraesthesia, Dry throat, Throat tightness, Dyspnoea, Feeling hot, Sinus disorder, Insomnia, Anxiety, Decreased appetite, |
||||
DUPILUMAB, LORAZEPAM, LORAZEPAM, |
||||
| 2676 | 25293250 |
US |
62 | 1 |
Fatigue, Functional gastrointestinal disorder, Brain fog, Decreased appetite, Pollakiuria, Micturition urgency, Hot flush, Paraesthesia, Vision blurred, Dysuria, Nausea, Underdose, |
||||
TAMSULOSIN HYDROCHLORIDE, ENZALUTAMIDE, RELUGOLIX, RELUGOLIX, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, CELECOXIB, ERGOCALCIFEROL, GABAPENTIN, LISINOPRIL, |
||||
| 2677 | 25293998 |
US |
60 | 2 |
Muscular weakness, Fine motor skill dysfunction, Hypoaesthesia, Paraesthesia, Gait disturbance, Coordination abnormal, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 2678 | 25285153 |
US |
82 | 2 |
Rubber sensitivity, Injection site discolouration, Paraesthesia, Injection site haemorrhage, |
||||
EVOLOCUMAB, EVOLOCUMAB, |
||||
| 2679 | 25285442 |
US |
||
Paraesthesia, Dyspepsia, |
||||
CILTACABTAGENE AUTOLEUCEL, LENALIDOMIDE, |
||||
| 2680 | 25285544 |
US |
1 | |
Cytokine release syndrome, Anhidrosis, Paraesthesia, |
||||
TALQUETAMAB, |
||||
| 2681 | 25285647 |
CA |
40 | 2 |
Wound infection, Abdominal discomfort, Abdominal distension, Adverse reaction, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Blood cholesterol increased, C-reactive protein increased, Coeliac disease, Condition aggravated, Confusional state, Drug hypersensitivity, Drug intolerance, Dyspepsia, Dyspnoea, Exposure during pregnancy, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Muscular weakness, Musculoskeletal pain, Musculoskeletal stiffness, Nail disorder, Nasopharyngitis, Nausea, Neck pain, Night sweats, Off label use, Onychomadesis, Osteoarthritis, Pain, Pain in extremity, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Pneumonia, Product label confusion, Product quality issue, Psoriatic arthropathy, Rash, Rheumatic fever, Sleep disorder, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Taste disorder, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Wheezing, Wound, Fatigue, Finger deformity, Folliculitis, Gait inability, Gastrointestinal disorder, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Grip strength decreased, Hand deformity, Headache, Helicobacter infection, Hepatic enzyme increased, Hepatitis, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Inflammation, Infusion related reaction, Injection site reaction, Injury, Insomnia, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Live birth, Liver function test increased, Liver injury, Lower respiratory tract infection, Lung disorder, Malaise, Maternal exposure during pregnancy, Memory impairment, |
||||
ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN AND CODEINE, ACETAMINOPHEN AND CODEINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ERENUMAB-AOOE, ERENUMAB-AOOE, ERENUMAB-AOOE, ERENUMAB-AOOE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, APREMILAST, APREMILAST, APREMILAST, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ATOMOXETINE, ATOMOXETINE, AZATHIOPRINE SODIUM, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, CANDESARTAN, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ERGOCALCIFEROL, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, GOLD, GOLIMUMAB, GOLIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE BUTYRATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, INFLIXIMAB, INFLIXIMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, SARILUMAB, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, MINOCYCLINE, MINOCYCLINE, MINOCYCLINE, MINOCYCLINE, MINOCYCLINE HYDROCHLORIDE, MIRABEGRON, MIRABEGRON, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NICOTINAMIDE, MEPOLIZUMAB, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, APREMILAST, OXYCODONE, PHENYLEPHRINE HYDROCHLORIDE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, RAMIPRIL, RAMIPRIL, RAMIPRIL, RANITIDINE, RANITIDINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, SULFASALAZINE, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, |
||||
| 2682 | 25285717 |
US |
58 | 2 |
Back pain, Dyspnoea, Eye pruritus, Chest discomfort, Dizziness, Nausea, Dysphonia, Wheezing, Chest discomfort, Abdominal discomfort, Paraesthesia, |
||||
| 2683 | 25286096 |
GB |
59 | 2 |
Paraesthesia, Hypoaesthesia, |
||||
GABAPENTIN, BACLOFEN, |
||||
| 2684 | 25286257 |
GB |
52 | 2 |
Musculoskeletal stiffness, Multiple sclerosis, Balance disorder, Muscle tightness, Cognitive disorder, Gait disturbance, Weight increased, Paraesthesia, Contusion, Memory impairment, Fatigue, Pain, |
||||
NATALIZUMAB, |
||||
| 2685 | 25286530 |
CA |
||
Laparoscopic surgery, Eye oedema, Paraesthesia, Infection prophylaxis, Blood pressure systolic increased, Pain in extremity, Balance disorder, Cellulitis, Infusion site irritation, Treatment delayed, |
||||
RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, METHYLPREDNISOLONE, PREDNISONE, METHOTREXATE, METHOTREXATE SODIUM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, PREGABALIN, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, ALENDRONATE SODIUM, ALENDRONATE SODIUM TABLET, |
||||
| 2686 | 25286976 |
US |
1 | |
Application site pain, Paraesthesia, Pain, |
||||
CAPSAICIN, OXYCODONE, OXYCODONE, OXYCODONE, |
||||
| 2687 | 25287187 |
GB |
30 | 1 |
Paraesthesia, Palpitations, Pain, Hyperaesthesia, Allodynia, Sensitive skin, Dizziness postural, Disturbance in attention, Small fibre neuropathy, Autonomic neuropathy, |
||||
CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, |
||||
| 2688 | 25287388 |
GB |
2 | |
Pharyngeal swelling, Dizziness, Paraesthesia, Chest pain, Blood pressure increased, Hypersensitivity, |
||||
USTEKINUMAB-TTWE, |
||||
| 2689 | 25287623 |
GB |
59 | 2 |
Hypoaesthesia, Paraesthesia, |
||||
BACLOFEN, GABAPENTIN, |
||||
| 2690 | 25287938 |
GB |
66 | 2 |
Muscle spasms, Abdominal pain upper, Dyspnoea, Paraesthesia, Burning feet syndrome, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, RAMIPRIL, ROSUVASTATIN, AMLODIPINE, DAPAGLIFLOZIN, |
||||
| 2691 | 25288091 |
SE |
59 | 2 |
Loss of consciousness, Pain in jaw, Tremor, Chest pain, Chills, Back pain, Tachycardia, Dyspnoea, Pain in extremity, Thinking abnormal, Peripheral coldness, Hypersomnia, Dizziness, Asthenia, Feeling abnormal, Palpitations, Paraesthesia, Fatigue, Blood potassium decreased, Dysgeusia, Constipation, Muscle twitching, Sedation, Vertigo, Discomfort, Feeling cold, Mood altered, Feeling drunk, Oropharyngeal pain, Coxsackie virus test positive, Orthostatic hypotension, Neuralgia, Affect lability, Hypertension, Asthma, Confusional state, Cough, Nystagmus, Headache, Pyrexia, Somnolence, Inappropriate schedule of product administration, |
||||
IVERMECTIN, IVERMECTIN, LEVOTHYROXINE, OLOPATADINE, MELATONIN, ASCORBIC ACID, DOXYCYCLINE, DOXYCYCLINE HYCLATE, POTASSIUM CITRATE, PIOGLITAZONE, ERGOCALCIFEROL, PRASTERONE, PROGESTERONE, COLESEVELAM, MONTELUKAST, DESVENLAFAXINE, DESVENLAFAXINE SUCCINATE, |
||||
| 2692 | 25288380 |
BE |
55 | 2 |
Paraesthesia, Calculus urinary, Depression, Aphasia, Drug interaction, |
||||
TOPIRAMATE, TOPIRAMATE, ESCITALOPRAM OXALATE, ESCITALOPRAM, |
||||
| 2693 | 25288499 |
US |
||
Hypoaesthesia, Paraesthesia, Tongue discomfort, Eye pain, Pain in extremity, |
||||
UBLITUXIMAB, UBLITUXIMAB, GABAPENTIN, |
||||
| 2694 | 25288676 |
US |
63 | 2 |
Dry skin, Paraesthesia, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 2695 | 25288758 |
US |
2 | |
Hypoaesthesia, Paraesthesia, Ataxia, Balance disorder, Muscular weakness, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 2696 | 25288841 |
40 | 2 | |
Hypoaesthesia, Paraesthesia, Spinal disorder, Treatment failure, Therapy change, |
||||
GLATIRAMER ACETATE, |
||||
| 2697 | 25288868 |
US |
38 | 2 |
Neuropathy peripheral, Back pain, Pain in extremity, Pain, Paraesthesia, Depression, Initial insomnia, Decreased appetite, Feeling abnormal, Muscle spasms, Myalgia, Inappropriate schedule of product administration, |
||||
CERTOLIZUMAB PEGOL, HYDROXYZINE, QUETIAPINE, TRIAMTERENE CAPSULES, TRIAMTERENE, CELECOXIB, DULOXETINE HYDROCHLORIDE, DULOXETINE, GABAPENTIN, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, NORETHINDRONE ACETATE, NORETHINDRONE, POTASSIUM CHLORATE, PREGABALIN, |
||||
| 2698 | 25289098 |
IL |
26 | 2 |
Syncope, Chills, Headache, Muscular weakness, Paraesthesia, Vomiting, Nausea, Heart rate increased, Sensitive skin, C-reactive protein increased, Somnolence, Allodynia, Dysuria, Viral infection, Disturbance in attention, Fatigue, Dyspepsia, Asthenia, |
||||
TIRZEPATIDE, |
||||
| 2699 | 25289486 |
CA |
44 | 2 |
Paraesthesia, Throat irritation, |
||||
GADOTERIDOL, |
||||
| 2700 | 25289530 |
US |
70 | 2 |
Raynaud^s phenomenon, Peripheral swelling, Pain, Movement disorder, Arthralgia, Feeling abnormal, Breast pain, Pain in extremity, Neck pain, Paraesthesia, |
||||
DICLOFENAC SODIUM, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, IBUPROFEN TABLET COATED, INCLISIRAN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, INCLISIRAN, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-10-30